Summit Partners Public Asset Management LLC decreased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 19.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 52,296 shares of the biotechnology company’s stock after selling 13,020 shares during the period. Summit Partners Public Asset Management LLC’s holdings in Axon Enterprise were worth $20,897,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Tidal Investments LLC raised its stake in Axon Enterprise by 22.4% in the first quarter. Tidal Investments LLC now owns 4,833 shares of the biotechnology company’s stock worth $1,512,000 after buying an additional 884 shares in the last quarter. Cetera Investment Advisers raised its position in shares of Axon Enterprise by 280.6% in the 1st quarter. Cetera Investment Advisers now owns 21,067 shares of the biotechnology company’s stock worth $6,592,000 after acquiring an additional 15,532 shares in the last quarter. Cetera Advisors LLC lifted its stake in shares of Axon Enterprise by 49.7% during the 1st quarter. Cetera Advisors LLC now owns 7,623 shares of the biotechnology company’s stock worth $2,385,000 after purchasing an additional 2,532 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its position in Axon Enterprise by 45.4% during the first quarter. DekaBank Deutsche Girozentrale now owns 16,986 shares of the biotechnology company’s stock valued at $5,321,000 after purchasing an additional 5,301 shares in the last quarter. Finally, Capital Market Strategies LLC grew its stake in Axon Enterprise by 82.0% in the second quarter. Capital Market Strategies LLC now owns 2,650 shares of the biotechnology company’s stock valued at $780,000 after purchasing an additional 1,194 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.
Axon Enterprise Trading Up 0.4 %
Shares of NASDAQ:AXON opened at $634.96 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52-week low of $224.28 and a 52-week high of $641.20. The stock has a market cap of $48.42 billion, a price-to-earnings ratio of 164.07, a PEG ratio of 13.97 and a beta of 0.94. The business has a 50-day moving average price of $478.27 and a 200-day moving average price of $374.80.
Analyst Ratings Changes
Get Our Latest Stock Report on AXON
Insider Buying and Selling
In other news, CFO Brittany Bagley sold 4,338 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the sale, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. This represents a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 75,000 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total value of $26,739,750.00. Following the transaction, the chief executive officer now owns 2,970,366 shares of the company’s stock, valued at approximately $1,059,024,589.98. This represents a 2.46 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 210,256 shares of company stock worth $87,783,120. 6.10% of the stock is owned by company insiders.
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What Does Downgrade Mean in Investing?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Market Cap Calculator: How to Calculate Market Cap
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Investing in the High PE Growth Stocks
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.